{"disease":{"id":"t2dm-type-2-diabetes-mellitus","name":"t2dm type 2 diabetes mellitus"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07421921","title":"Detecting Type 2 Diabetes From Voice","phase":"","overall_status":"COMPLETED","enrollment_count":7319,"lead_sponsor_name":"Thymia Limited","has_results":false},{"nct_id":"NCT06293417","title":"To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM","phase":"NA","overall_status":"RECRUITING","enrollment_count":3958,"lead_sponsor_name":"Korea University Anam Hospital","has_results":false},{"nct_id":"NCT06694012","title":"Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Osaka Metropolitan University","has_results":false},{"nct_id":"NCT07116928","title":"Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":1244,"lead_sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06976541","title":"Utilization Study and Evaluation of Educational Intervention on HbA1c Testing","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":968,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06094491","title":"Virtual Diabetes Group Visits Across Health Systems","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":720,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT05680129","title":"A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Hangzhou Sciwind Biosciences Co., Ltd.","has_results":false},{"nct_id":"NCT03658031","title":"Effect of Dapagliflozin on the Progression From Prediabetes to T2DM in Subjects With Myocardial Infarction","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":576,"lead_sponsor_name":"Hamad Medical Corporation","has_results":false},{"nct_id":"NCT03437109","title":"Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus","phase":"","overall_status":"COMPLETED","enrollment_count":554,"lead_sponsor_name":"Besins Healthcare","has_results":false},{"nct_id":"NCT06733805","title":"Impact Evaluation of the Therapeutic Initiative's Type 2 Diabetes in Older Adults Portrait and Therapeutics Letter","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":515,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT07244003","title":"Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":430,"lead_sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06350890","title":"Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":408,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":false},{"nct_id":"NCT03467932","title":"A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":373,"lead_sponsor_name":"Oramed, Ltd.","has_results":true},{"nct_id":"NCT06415773","title":"Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With Type 2 Diabetes Inadequately Controlled With Metformin","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":367,"lead_sponsor_name":"HighTide Biopharma Pty Ltd","has_results":false},{"nct_id":"NCT04754334","title":"A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":346,"lead_sponsor_name":"Oramed, Ltd.","has_results":false},{"nct_id":"NCT07441187","title":"Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT07303803","title":"A Study of Chiglitazar in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes Mellitus","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04654390","title":"The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":270,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT05680155","title":"A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":211,"lead_sponsor_name":"Hangzhou Sciwind Biosciences Co., Ltd.","has_results":false},{"nct_id":"NCT06254274","title":"A Study of RAY1225 in Participants With Type 2 Diabetes","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":210,"lead_sponsor_name":"Guangdong Raynovent Biotech Co., Ltd","has_results":false},{"nct_id":"NCT04682795","title":"Comparison of Safety and Efficacy of Needle-Free Injector and Insulin Pen in Patients With T2DM","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04634500","title":"The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT05943886","title":"A Phase 1 Study of HEC88473 Injection in Healthy Subjects, Obese Subjects and T2DM Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Dongguan HEC Biopharmaceutical R&D Co., Ltd.","has_results":false},{"nct_id":"NCT07172997","title":"Non-Invasive MASLD Diagnosis & T2D Remission Biomarkers","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":163,"lead_sponsor_name":"Royal College of Surgeons in Ireland - Medical University of Bahrain","has_results":false},{"nct_id":"NCT05376969","title":"Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT06712615","title":"Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":144,"lead_sponsor_name":"ProGen. Co., Ltd.","has_results":false},{"nct_id":"NCT04632862","title":"The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT04272359","title":"Substitution of Sulfonylureas With New Generation of Hypoglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus","phase":"","overall_status":"UNKNOWN","enrollment_count":138,"lead_sponsor_name":"University of Milan","has_results":false},{"nct_id":"NCT06055582","title":"To Study the Effects of Mango Ingestion in T2DM and Non-diabetic Subjects.","phase":"NA","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"Diabetes Foundation, India","has_results":false},{"nct_id":"NCT06912737","title":"Group Emotion-Focused Behavioral Intervention for Diabetes Distress/A1c in T2D.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT05469659","title":"Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Shinshu University","has_results":false},{"nct_id":"NCT05260021","title":"A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT07188935","title":"Glycemia and Antibiotic Efficacy in Diabetic Recurrent UTIs","phase":"NA","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"Al-Mustansiriyah University","has_results":false},{"nct_id":"NCT04688359","title":"Effectiveness of Nurse-coordinated Follow-up Program in Primary Care for People at Risk for T2DM","phase":"NA","overall_status":"COMPLETED","enrollment_count":81,"lead_sponsor_name":"University of Akureyri","has_results":false},{"nct_id":"NCT07314684","title":"GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT07026539","title":"Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT07519265","title":"Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Chipscreen Biosciences, Ltd.","has_results":false},{"nct_id":"NCT05376930","title":"Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Daewoong Pharmaceutical Co. LTD.","has_results":false},{"nct_id":"NCT05983289","title":"Single Escalating Dose Study Of HSK7653 In Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT05279911","title":"Effect of Low-level Laser Therapy on Type II Controlled Diabetic Patients After Dental Implant Insertion","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Sinai University","has_results":false},{"nct_id":"NCT07390422","title":"Duodenal ReCET for Suboptimally Controlled Type II Diabetes Mellitus and Steatotic Liver Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT07005362","title":"Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D","phase":"","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"University of Colorado, Denver","has_results":false},{"nct_id":"NCT04970940","title":"The Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"AJU Pharm Co., Ltd.","has_results":false},{"nct_id":"NCT07511010","title":"Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Chipscreen Biosciences, Ltd.","has_results":false},{"nct_id":"NCT04706286","title":"Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":26,"lead_sponsor_name":"Chong Kun Dang Pharmaceutical","has_results":false},{"nct_id":"NCT07412015","title":"Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Chipscreen Biosciences, Ltd.","has_results":false},{"nct_id":"NCT01373814","title":"Nutritional Therapy for Diabetic Cardiomyopathy","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05369078","title":"Safety, Tolerance and Pharmacokinetics of THR-1442 in Chinese Healthy Subjects","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":16,"lead_sponsor_name":"Newsoara Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT03067480","title":"Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients","phase":"NA","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"East Tennessee State University","has_results":true},{"nct_id":"NCT03291249","title":"Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Tiziana Life Sciences LTD","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}